Neuberg Diagnostics launches NCGM, its first Laboratory in the USA

Neuberg Diagnostics, a global laboratory testing group, announced the start of its clinical laboratory operations in North Carolina in the United States of America (USA).

The laboratory in North Carolina, known as NCGM, Inc. (Neuberg Centre for Genomic Medicine), will focus on genomic and molecular testing based on new generation sequencing techniques. It also runs an extensive network of labs in India, South Africa, and the UAE as well.

NCGM has introduced COVID-19 molecular testing to detect active SARS CoV-2 virus infections that is of immediate public health priority in North America, along with genome-scale testing, such as Exome Sequencing, which is applicable across a variety of Rare Genetic Disease Testing (Inherited Diseases) from Newborn Screening to Oncology to Pediatric Care Setting.

Dr. GSK Velu, Chairman & Managing Director of Neuberg Diagnostics, said, “NCGM, USA will act as the laboratory and hub, aiding our operations in North America. Through leveraging our collaborative efforts across our organization in India, South Africa, and UAE, and with our external partners, we aim to develop and provide the best-in-class affordable tests.”

“As they are deployed, the accessibility and affordability of the tests will reduce disparity and benefit individuals across the board.” He added.

Dr. Sandip Shah, Executive Director Neuberg Diagnostics, said “NCGM, USA Sequencing services will be supported by in-house bioinformatics team and cutting-edge technologies which have been developed inhouse, and along with reputed partners. It will also support genetic research by leveraging our own extensive infrastructure in India, South Africa, and UAE.”

Dr. Andy Bhattacharjee, CEO, NCGM, USA, said, “The setup has comprehensive Genomic testing facility allowing large-scale clinical and research projects. With the capacity to conduct more than 400 varieties of tests, the center will conduct large-scale clinical diagnostics and genomics projects with greater sample volumes at an unprecedented depth and coverage of the genome.”

“Currently, we are offering Covid RT-PCR Testing Services at our NC Lab with home sample collection facilities in association with FexEx to help fight the pandemic in the USA too.”  He added.

For more information about NCGM, USA, please visit – http://www.ncgm.us/ or write to us at [email protected] or call us at252 371 1584

About Neuberg Diagnostics: 

Best-in-class laboratories across India, the USA, UAE & South Africa have united under the banner of Neuberg Diagnostics, to bring the latest technology and techniques within the reach of developing countries. Utilizing their combined strengths, the Neuberg Alliance brings capabilities to perform over 6000 varieties of Pathological investigations and promotes Prevention & Early Diagnosis, Focused Wellness Programs, and Structured Disease Management programs for rare diseases using the most advanced technologies assisted by Data science and AI tools.

Today, Neuberg Diagnostics is among the top diagnostics companies of Indian origin and the fastest growing healthcare start-up in India. The founding members of the Neuberg consortium – Anand Diagnostic Laboratory (Bangalore), Supratech Micropath (Ahmedabad), Ehrlich Laboratory (Chennai), Global Labs (South Africa), and Minerva Diagnostics (Dubai) bring their combined heritage of over 200 years, and process over 20 million tests annually.

The group has 18 approved labs for Covid testing in India, South Africa, and the USA. Some of the best Pathologists, Biochemists, Geneticists, Microbiologists, and several other Clinical Lab Professionals from around the world are working closely, sharing knowledge, and using the latest generation of diagnostics techniques to take accurate and timely diagnoses to the next level.

Neuberg expansion plans include establishing a presence in East Africa, West Africa, the USA, and Germany.

MEDIA RELEASE